Beta Bionics (BBNX) Current Assets (2023 - 2026)

Beta Bionics has disclosed Current Assets across 4 years of filings, most recently posting $231.0 million for Q2 2026.

• In Q2 2026, Current Assets fell 19.24% year-over-year to $231.0 million; the TTM figure through Jun 2026 stood at $231.0 million (down 19.24% YoY), while the FY2025 annual figure was $267.9 million, up 101.55% from the prior year.
• Current Assets came in at $231.0 million for Q2 2026 at Beta Bionics, down from $248.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $286.1 million in Q2 2025 to a low of $103.6 million in Q4 2023.
• Average Current Assets over 4 years is $225.2 million, with a median of $255.0 million recorded in 2025.
• Year-over-year, Current Assets jumped 101.55% in 2025 and decreased 19.24% in 2026.
• Over 4 years, Current Assets stood at $103.6 million in 2023, then climbed by 28.28% to $132.9 million in 2024, then jumped by 101.55% to $267.9 million in 2025, then retreated by 13.76% to $231.0 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $231.0 million in Q2 2026, $248.0 million in Q1 2026, and $267.9 million in Q4 2025.